SOHO 2019
Advertisement
According to a study, patients with myelofibrosis (MF) who presented with low baseline platelet counts achieved spleen ...
Cardiac, vascular and hypertension treatment-emergent adverse events (TEAE) rates were similarly low with the tyrosine ...
Pregnant patients with chronic myeloid leukemia (CML) should be treated according to major molecular response (MMR) and ...
Assessing the therapeutic management of immune manifestations associated with chronic myelomonocytic leukemia (CMML) ...
Researchers have confirmed that simple and rapid JAK2V617F peripheral blooding testing is a vital component of diagnosis ...
Among Egyptian patients, early identification additional chromosomal abnormalities (ACAs) in Ph+ metaphases in chronic ...
Comprehending the full value of ruxolitinib for polycythemia vera (PV) and myelofibrosis (MF) patients is critical for ...
Allogeneic hematopoietic cell transplantation (allo-HCT) used in conjunction with fludarabine/melphalan (Flu/Mel) ...
Most pretreated patients with Philadelphia chromosome–positive (Ph+ CP) chronic myeloid leukemia experienced confirmed ...
Disease progression in myelofibrosis (MF) can take many forms, as detailed in this review published in the SOHO 2019 ...
While myelofibrosis (MF) patients with ruxolitinib (rux) failure continue to represent an unmet medical need, they also ...
Despite significant progress being made in the management of chronic myeloid leukemia (CML) which has allowed many to ...
DocWire News will provide coverage of the seventh annual Society of Hematologic Oncology Meeting (SOHO 2019), which will ...
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.